Results 51 to 60 of about 6,286,028 (355)

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis ...
Maya L. Mastick   +19 more
wiley   +1 more source

Sex Differences in Medication Discontinuation in Axial Spondyloarthritis

open access: yesArthritis Care &Research, EarlyView.
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall   +9 more
wiley   +1 more source

Market Consistent Pricing of Insurance Products [PDF]

open access: yesSSRN Electronic Journal, 2007
We present the first step in a program to develop a comprehensive, unified equilibrium theory of asset and liability pricing. We give a mathematical framework for pricing insurance products in a multiperiod financial market. This framework reflects classical economic principles (like utility maximization) and generates pricing algorithms for non ...
Malamud, Semyon   +2 more
openaire   +4 more sources

A Legal Framework for Net Zero Aligned Insurance Products

open access: yes, 2023
Keywords: decarbonisation, net-zero, insurance, impact underwriting, insurance product designKeywords: decarbonisation, net-zero, insurance, impact underwriting, insurance product designKeywords: decarbonisation, net-zero, insurance, impact underwriting,
Arnold-Dwyer, F
core  

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

open access: yesArthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr   +5 more
wiley   +1 more source

Modern Trends Functioning of the Insurance Services Market of Russia

open access: yesУправленческое консультирование, 2018
At the present stage, there is a further development of the insurance market, which is associated with the integration processes taking place on it, affecting the participants of insurance activities.
A. A. Polyakova   +2 more
doaj   +1 more source

مكانة أصول الفقه في التأمين الشرعي: دراسة التأمين الشرعي لمستقبل الأطفال من أكسا مانديري الشريعة

open access: yesAl-Zahra: Journal for Islamic and Arabic Studies, 2023
Amid the many choices of conventional insurance products that are echoed by the private sector and the government, such as health insurance, education, employment, and old age insurance.
Rusli Hasbi
doaj   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Insurance developmen problems property of legal entities in depressive regions

open access: yesУченые записки Российской академии предпринимательства, 2021
Article opens the main problems of development of insurance of property of legal entities in depressive regions. The analysis of the reasons of the low involvement of the enterprises located in the territory of depressive regions is carried out to ...
O. I. Bashlakova
doaj  

Home - About - Disclaimer - Privacy